Loading
Medical oncologist who chairs the board of IPO Porto, the public cancer hospital serving northern Portugal, since 2022.
Júlio Oliveira is Presidente do Conselho de Administração of the Instituto Português de Oncologia do Porto Francisco Gentil (IPO Porto), the National Health Service oncology hospital that is the reference cancer centre for northern Portugal. A medical oncologist, he has chaired the board since it took office in October 2022 and was reappointed for a further three-year term in 2026. In 2024 he was elected to the board of the Organisation of European Cancer Institutes (OECI) as Executive Secretary for the 2024 to 2027 term, and in 2025 he led the creation of an association to promote clinical research at the institute.
| Title | Journal | Year |
|---|---|---|
| Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-Oncology Agents in Resectable Lung Cancer: The Phase II NeoCOAST Platform Trial | Cancer Discovery | 2023 |
Shares Instituto Português de Oncologia de Lisboa Francisco Gentil, Instituto Português de Oncologia do Porto Francisco Gentil, Organisation of European Cancer Institutes.
Shares Instituto Português de Oncologia de Lisboa Francisco Gentil and the tag leadership.
Shares the tags leadership, clinician-scientist, medical-oncology.
Shares the tags leadership, clinician-scientist, medical-oncology.
Shares Instituto Português de Oncologia de Lisboa Francisco Gentil, Organisation of European Cancer Institutes and the tag leadership.
Shares Organisation of European Cancer Institutes and the tags leadership, clinician-scientist.
Shares the tags leadership, clinician-scientist, medical-oncology.
Shares the tags leadership, clinician-scientist, medical-oncology.